Tags |
|
|
Links |
|
|
Just Other Articles - Business Innovation - Organizational Structure
Creativity can be defined as problem identification and idea generation whilst innovation can be defined as idea selec
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
tion, development and commercialisation.
There are other useful definitions in this field, for example, creativity ca
There are other useful definitions in this field, for example, creativity ca
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
be defined as consisting of a number of ideas, a number of diverse ideas and a number of novel ideas.
There are dist
There are dist
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
nct processes that enhance problem identification and idea generation and, similarly, distinct processes that enhance
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
dea selection, development and commercialisation. Whilst there is no sure fire route to commercial success, these proc
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
sses improve the probability that good ideas will be generated and selected and that investment in developing and comm
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
rcialising those ideas will not be wasted.
Organizational Structure
Reality tells us that there are many re
Organizational Structure
Reality tells us that there are many re
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
asons why an organisation's structure has its shape (logistics, organic growth, history, size, market share, future st
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
ategy) and is, like organisational culture, not easily changed or restructured. Often, there are valid reasons not to
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
ake structural adjustments at all.
Thus leaders require, not recommendations for complete restructure, but knowledge
Thus leaders require, not recommendations for complete restructure, but knowledge
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
f fostering properties that can be easily adapted into the existing structure. This fits with research that indicates
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
hat people who generate ideas on a regular basis find structure to be unimportant as long as some criteria are met. A
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
ew of these include:
a) Direct access to decision makers – provides fast feedback and immediate go or kill decisions.
a) Direct access to decision makers – provides fast feedback and immediate go or kill decisions.
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
b) Short lines of communication – if communication gets filtered there is a loss of momentum and corresponding loss o
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
f control.
c) Tangible progression – if ideas are not picked up at all, motivation suffers.
In fact, a huge number o
c) Tangible progression – if ideas are not picked up at all, motivation suffers.
In fact, a huge number o
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
other issues ought to be considered.
These and other topics are covered in depth in the MBA dissertation on Managing
These and other topics are covered in depth in the MBA dissertation on Managing
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
Creativity & Innovation, which can be purchased (along with a Creativity and Innovation DIY Audit, Good Idea Generator
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
Software and Power Point Presentation) from http://www.man
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
ging-creativity.com/
You can also receive a regular, free newsletter by entering your email address at this site.
You can also receive a regular, free newsletter by entering your email address at this site.
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
You are free to reproduce this article as long as no changes are made and the author's name and site URL are retained
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.justotherarticles.org.ua/article/24217/justotherarticles-Business-Innovation--Organizational-Structure.html">Business Innovation - Organizational Structure</a>
BB link (for phorums):
[url=http://www.justotherarticles.org.ua/article/24217/justotherarticles-Business-Innovation--Organizational-Structure.html]Business Innovation - Organizational Structure[/url]
Related Articles:
Customer No Service - How to Lose a Loyal Customer!
Inspiration for the Entrepreneur
The Top 10 Things They Don't Teach You In Business School
Bookmark it:
|